Clinical trials
Phase 3 Respiratory Tract Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Completed | 1 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ArriVent BioPharma, Inc. | 1 |
| Daiichi Sankyo | 1 |
| Eli Lilly and Company | 1 |
| Fundación GECP | 1 |
| Hoffmann-La Roche | 1 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 |
| Qilu Pharmaceutical Co., Ltd. | 1 |
| Sumitomo Pharma America, Inc. | 1 |
| University of Turin, Italy | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 9 |
| Respiratory Tract Neoplasms | 9 |
| Lung Neoplasms | 8 |
| Thoracic Neoplasms | 8 |
| Bronchial Neoplasms | 7 |
| Lung Diseases | 7 |
| Carcinoma, Bronchogenic | 6 |
| Neoplasms | 6 |
| Neoplasms by Site | 6 |
| Respiratory Tract Diseases | 6 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.